CRISPR Meets Proteomics: How IsoPlexis' Single Cell Data is Revolutionizing Therapeutic Genome Editing

Zhu H et al. Notch Activation Rescues Exhaustion in CISH-Deleted Human iPSC-Derived Natural Killer Cells to Promote in Vivo Persistence and Enhance Anti-Tumor Activity. Blood, 132 (Supplement 1): 1279, 2018.

Zhu H et al. Metabolic Reprogramming via Depletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity. Cell Stem Cell, 27: 1–14, 2020.

Srivastava K et al. Abbreviated T-cell activation on the automatic CliniMACS Prodigy device enhances bispecific CD19/22 Chimeric Antigen Receptor T-cell viability and fold expansion, reducing total culture duration. Presented at ASH Annual Meeting, 2018.

Schmidts A et al. Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. Blood Advances, 3: 3248–3260, 2019.

Li D et al. Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice. Gastroenterology, 158: 2250–2265, 2020.